# Chinese biotech out-licensing hits $137.7B in 2025, tenfold rise from 2021 - Date: 2026-04-15 - Category: Biotech & Life Sciences China originated $137.7B in drug licensing deals last year. Now Western pharma is paying billions to rent the molecules it used to own. ---